Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
FP13 - Immunotherapy (Phase II/III Trials)
- Type: Posters (Featured)
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 4
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP13.01 - 5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel in Previously Treated, PD-L1–Positive Advanced NSCLC
00:00 - 00:00 | Presenter: Roy S. Herbst
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
FP13.03 - IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1–Selected NSCLC
00:00 - 00:00 | Presenter: Roy S. Herbst
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P01 - Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
- Type: Posters
- Track: Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
- Presentations: 24
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P01.21 - ANSELMA: Antiangiogenic Second Line Lung Cancer Meta-Analysis on Individual Patient Data in Non-Small Cell Lung Cancer, Again Relevant in ICI Era
00:00 - 00:00 | Presenter: Jordi Remon
- Abstract
Loading...
-
+
P09 - Health Services Research/Health Economics - Real World Outcomes
- Type: Posters
- Track: Health Services Research/Health Economics
- Presentations: 60
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P09.55 - A Platform to Prospectively Link Real-World Clinico-Genomic, Imaging, and Outcomes Data for Patients With Lung Cancer
00:00 - 00:00 | Presenter: Guneet Walia
- Abstract
Loading...
-
+
IS05 - Industry Symposium Sponsored by MSD: Redefining Survival Expectations in Lung Cancer
- Type: Industry Symposium
- Track:
- Presentations: 5
- Coordinates: 1/28/2021, 14:15 - 15:15, Industry Symposia Auditorium (via Industry Hub)
-
+
IS05.03 - Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Lung Cancer
14:30 - 14:45 | Presenter: Roy S. Herbst
- Abstract
No abstract available for this presentation
-
+
IS05.05 - Q&A and Closing Remarks
15:00 - 15:15 | Presenter: Rina Hui
- Abstract
No abstract available for this presentation
-
+
OA01 - Established Drugs in Special Populations and New Drugs in Established Populations
- Type: Oral
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 9
- Coordinates: 1/29/2021, 09:15 - 10:15, Scientific Program Auditorium
-
+
OA01.04 - Tumor Mutation Burden (TMB) by Next Generation Sequencing (NGS) Associates with Survival (OS) in Lung-MAP Immunotherapy Trials S1400I and S1400A
09:25 - 09:35 | Presenter: Fred R Hirsch
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ES02 - Pro-Con: Do We Need Biomarkers to Guide the Choice of Immunotherapy Treatment?
- Type: Educational Session
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 4
- Coordinates: 1/29/2021, 10:30 - 11:30, Scientific Program Auditorium
-
+
ES02.03 - We Should Use IO Alone as Maintenance
11:00 - 11:15 | Presenter: Roy S. Herbst
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA06 - Updates on EGFR Targeted Perioperative Therapy and Precision Adjuvant Chemotherapy
- Type: Oral
- Track: Early Stage/Localized Disease
- Presentations: 8
- Coordinates: 1/29/2021, 16:45 - 17:45, Scientific Program Auditorium
-
+
OA06.03 - Patient-Reported Outcomes from ADAURA: Osimertinib as Adjuvant Therapy in Patients with Resected EGFR Mutated (EGFRm) NSCLC
16:45 - 16:55 | Presenter: Margarita Majem
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA06.04 - Postoperative Chemotherapy Use and Outcomes from ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR Mutated NSCLC
16:55 - 17:05 | Presenter: Yi-long Wu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA08 - Advances in Biomarkers for Immune Checkpoint Blockade and Targeted Therapy in Non Small Cell Lung Carcinoma
- Type: Mini Oral
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 13
- Coordinates: 1/30/2021, 16:45 - 17:45, Scientific Program Auditorium
-
+
MA08.10 - LUNGMAP Master Protocol (LUNGMAP): Concordance Between Plasma ctDNA and Tissue Molecular Analysis
17:20 - 17:25 | Presenter: Philip Christopher Mack
- Abstract
Loading...
-
+
MA11 - Expanding Targetable Genetic Alterations in NSCLC
- Type: Mini Oral
- Track: Targeted Therapy - Clinically Focused
- Presentations: 12
- Coordinates: 1/31/2021, 14:15 - 15:15, Scientific Program Auditorium
-
+
MA11.10 - Lung Master Protocol (Lung-MAP) Next Generation Sequencing Analysis of Advanced Squamous Cell Cancers (SWOG S1400)
14:50 - 14:55 | Presenter: David Kozono
- Abstract
Loading...
